| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hearing Loss, Sensorineural | 35 | 2024 | 781 | 6.350 |
Why?
|
| Hearing Loss | 30 | 2022 | 783 | 5.190 |
Why?
|
| Vestibular Aqueduct | 11 | 2023 | 73 | 2.860 |
Why?
|
| Deafness | 20 | 2024 | 459 | 2.630 |
Why?
|
| Audiometry, Pure-Tone | 9 | 2023 | 210 | 1.700 |
Why?
|
| Tonsillectomy | 16 | 2022 | 278 | 1.660 |
Why?
|
| Connexins | 13 | 2023 | 352 | 1.630 |
Why?
|
| Otitis Media | 11 | 2018 | 286 | 1.620 |
Why?
|
| Usher Syndromes | 3 | 2021 | 56 | 1.540 |
Why?
|
| Cochlear Implantation | 12 | 2023 | 316 | 1.530 |
Why?
|
| Cochlear Implants | 12 | 2023 | 339 | 1.410 |
Why?
|
| Hearing Loss, Unilateral | 3 | 2022 | 25 | 1.220 |
Why?
|
| Adenoidectomy | 12 | 2022 | 167 | 1.150 |
Why?
|
| Ear, Middle | 10 | 2015 | 339 | 0.960 |
Why?
|
| Diagnostic Techniques, Otological | 1 | 2021 | 11 | 0.750 |
Why?
|
| Child | 100 | 2023 | 80153 | 0.730 |
Why?
|
| Cytomegalovirus Infections | 3 | 2022 | 831 | 0.710 |
Why?
|
| Temporal Bone | 7 | 2015 | 683 | 0.710 |
Why?
|
| Lymphadenitis | 5 | 2018 | 99 | 0.700 |
Why?
|
| Torticollis | 2 | 2020 | 64 | 0.680 |
Why?
|
| Sexual Harassment | 1 | 2020 | 82 | 0.670 |
Why?
|
| Ear, Inner | 3 | 2015 | 425 | 0.660 |
Why?
|
| Child, Preschool | 78 | 2022 | 42230 | 0.650 |
Why?
|
| Middle Ear Ventilation | 5 | 2018 | 101 | 0.610 |
Why?
|
| Klippel-Feil Syndrome | 1 | 2018 | 19 | 0.610 |
Why?
|
| Otitis Media with Effusion | 8 | 2008 | 115 | 0.590 |
Why?
|
| Infant | 58 | 2023 | 36192 | 0.590 |
Why?
|
| Stomatitis, Aphthous | 4 | 2016 | 51 | 0.580 |
Why?
|
| Blindness | 1 | 2021 | 584 | 0.570 |
Why?
|
| Otolaryngology | 3 | 2022 | 693 | 0.570 |
Why?
|
| Vaccines, Conjugate | 1 | 2018 | 328 | 0.540 |
Why?
|
| Pharyngitis | 4 | 2016 | 219 | 0.520 |
Why?
|
| Hearing Loss, Mixed Conductive-Sensorineural | 2 | 2016 | 13 | 0.520 |
Why?
|
| Retropharyngeal Abscess | 1 | 2015 | 21 | 0.510 |
Why?
|
| Cochlear Nerve | 3 | 2012 | 202 | 0.510 |
Why?
|
| Postoperative Hemorrhage | 3 | 2020 | 415 | 0.510 |
Why?
|
| Vestibular Diseases | 3 | 2021 | 230 | 0.500 |
Why?
|
| Audiometry | 9 | 2016 | 253 | 0.500 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 2021 | 1651 | 0.500 |
Why?
|
| Pharyngeal Diseases | 2 | 2015 | 134 | 0.480 |
Why?
|
| Pneumococcal Vaccines | 1 | 2018 | 397 | 0.470 |
Why?
|
| Physicians, Women | 1 | 2020 | 508 | 0.460 |
Why?
|
| Workplace | 1 | 2020 | 863 | 0.450 |
Why?
|
| Office Visits | 1 | 2018 | 595 | 0.450 |
Why?
|
| Speech Perception | 4 | 2023 | 507 | 0.450 |
Why?
|
| Genetic Testing | 9 | 2022 | 3537 | 0.440 |
Why?
|
| Vestibular Function Tests | 5 | 2015 | 128 | 0.420 |
Why?
|
| Deglutition Disorders | 2 | 2018 | 625 | 0.420 |
Why?
|
| Hearing Aids | 3 | 2021 | 58 | 0.420 |
Why?
|
| Membrane Transport Proteins | 6 | 2016 | 1035 | 0.410 |
Why?
|
| Hearing Loss, Sudden | 1 | 2013 | 45 | 0.410 |
Why?
|
| Neck | 3 | 2018 | 734 | 0.400 |
Why?
|
| Hearing Loss, Conductive | 4 | 2016 | 159 | 0.400 |
Why?
|
| Labyrinth Diseases | 3 | 2010 | 151 | 0.390 |
Why?
|
| Alleles | 12 | 2021 | 6863 | 0.390 |
Why?
|
| Hearing | 5 | 2023 | 501 | 0.380 |
Why?
|
| DNA Mutational Analysis | 8 | 2016 | 4111 | 0.370 |
Why?
|
| Consensus | 1 | 2021 | 3123 | 0.370 |
Why?
|
| Cytomegalovirus | 1 | 2015 | 756 | 0.370 |
Why?
|
| Otitis Media, Suppurative | 6 | 1998 | 27 | 0.370 |
Why?
|
| Guideline Adherence | 1 | 2021 | 2220 | 0.360 |
Why?
|
| Hearing Loss, Bilateral | 3 | 2022 | 53 | 0.350 |
Why?
|
| Pedigree | 4 | 2024 | 4542 | 0.350 |
Why?
|
| Adolescent | 53 | 2021 | 88319 | 0.350 |
Why?
|
| Humans | 153 | 2024 | 761504 | 0.340 |
Why?
|
| Adenoids | 2 | 2008 | 35 | 0.330 |
Why?
|
| Mutation | 26 | 2024 | 30052 | 0.330 |
Why?
|
| Tubulin | 2 | 2024 | 693 | 0.320 |
Why?
|
| Genotype | 9 | 2021 | 12990 | 0.320 |
Why?
|
| Cystic Fibrosis | 3 | 2016 | 1285 | 0.320 |
Why?
|
| Retrospective Studies | 42 | 2023 | 80636 | 0.310 |
Why?
|
| Phosphorylcholine | 1 | 2008 | 153 | 0.300 |
Why?
|
| Saccharomyces cerevisiae Proteins | 7 | 2007 | 1841 | 0.300 |
Why?
|
| Cochlea | 5 | 2020 | 845 | 0.290 |
Why?
|
| Ambulatory Care | 1 | 2018 | 2775 | 0.280 |
Why?
|
| Infant, Newborn | 25 | 2023 | 26198 | 0.280 |
Why?
|
| Acute Disease | 4 | 2016 | 7237 | 0.280 |
Why?
|
| Male | 94 | 2024 | 360804 | 0.280 |
Why?
|
| Tomography, X-Ray Computed | 16 | 2015 | 20570 | 0.260 |
Why?
|
| Hearing Loss, Noise-Induced | 1 | 2008 | 144 | 0.260 |
Why?
|
| Female | 88 | 2024 | 392644 | 0.260 |
Why?
|
| Acetyltransferases | 3 | 2004 | 231 | 0.260 |
Why?
|
| Saccharomyces cerevisiae | 11 | 2006 | 2688 | 0.250 |
Why?
|
| Cost of Illness | 1 | 2015 | 1936 | 0.250 |
Why?
|
| Bacteriophages | 2 | 2020 | 378 | 0.250 |
Why?
|
| Myosins | 2 | 2021 | 405 | 0.250 |
Why?
|
| Music | 1 | 2008 | 245 | 0.240 |
Why?
|
| Semicircular Canals | 3 | 2011 | 203 | 0.240 |
Why?
|
| Vertigo | 3 | 2020 | 202 | 0.240 |
Why?
|
| Young Adult | 20 | 2021 | 59243 | 0.230 |
Why?
|
| Axoneme | 1 | 2024 | 25 | 0.230 |
Why?
|
| Hearing Tests | 2 | 2004 | 121 | 0.230 |
Why?
|
| Vestibular Evoked Myogenic Potentials | 2 | 2023 | 88 | 0.230 |
Why?
|
| Face | 2 | 2021 | 1026 | 0.230 |
Why?
|
| Ciliary Motility Disorders | 1 | 2024 | 51 | 0.230 |
Why?
|
| Centrioles | 1 | 2024 | 80 | 0.230 |
Why?
|
| Acoustic Impedance Tests | 6 | 2009 | 110 | 0.220 |
Why?
|
| Abnormalities, Multiple | 3 | 2021 | 1423 | 0.220 |
Why?
|
| Laryngeal Diseases | 3 | 2000 | 243 | 0.220 |
Why?
|
| Airway Obstruction | 6 | 2006 | 661 | 0.210 |
Why?
|
| Nuclear Envelope | 3 | 2007 | 163 | 0.210 |
Why?
|
| Hearing Disorders | 1 | 2003 | 126 | 0.210 |
Why?
|
| Vestibule, Labyrinth | 2 | 2023 | 234 | 0.210 |
Why?
|
| Neonatal Screening | 3 | 2018 | 597 | 0.210 |
Why?
|
| Ossicular Replacement | 1 | 2002 | 11 | 0.210 |
Why?
|
| Mutation, Missense | 2 | 2024 | 2571 | 0.200 |
Why?
|
| Anti-Bacterial Agents | 10 | 2018 | 7407 | 0.200 |
Why?
|
| Incus | 1 | 2002 | 19 | 0.200 |
Why?
|
| Auditory Threshold | 4 | 2018 | 369 | 0.200 |
Why?
|
| Gene Frequency | 5 | 2021 | 3606 | 0.200 |
Why?
|
| Reflex, Vestibulo-Ocular | 2 | 2015 | 86 | 0.200 |
Why?
|
| Lysine-tRNA Ligase | 1 | 2021 | 5 | 0.200 |
Why?
|
| CHARGE Syndrome | 1 | 2021 | 33 | 0.190 |
Why?
|
| Chromosome Segregation | 3 | 2015 | 235 | 0.190 |
Why?
|
| Genome, Viral | 3 | 2020 | 667 | 0.190 |
Why?
|
| Pain, Postoperative | 3 | 2020 | 1739 | 0.190 |
Why?
|
| Facial Paralysis | 1 | 2005 | 346 | 0.190 |
Why?
|
| Ductus Arteriosus, Patent | 2 | 2019 | 217 | 0.180 |
Why?
|
| Genes, Recessive | 4 | 2024 | 623 | 0.180 |
Why?
|
| Epiglottis | 1 | 2000 | 81 | 0.180 |
Why?
|
| Electroretinography | 2 | 2021 | 525 | 0.180 |
Why?
|
| Cholesteatoma | 2 | 1993 | 28 | 0.180 |
Why?
|
| Telemedicine | 1 | 2018 | 3051 | 0.180 |
Why?
|
| Genome, Human | 4 | 2024 | 4425 | 0.180 |
Why?
|
| Genetic Variation | 7 | 2021 | 6567 | 0.180 |
Why?
|
| Visual Field Tests | 2 | 2021 | 411 | 0.180 |
Why?
|
| Actinobacteria | 1 | 2020 | 59 | 0.170 |
Why?
|
| Audiology | 1 | 2020 | 23 | 0.170 |
Why?
|
| Nuclear Proteins | 7 | 2007 | 5796 | 0.170 |
Why?
|
| Cilia | 1 | 2024 | 495 | 0.170 |
Why?
|
| Nursing, Team | 1 | 1999 | 3 | 0.170 |
Why?
|
| Chromatids | 3 | 2004 | 62 | 0.170 |
Why?
|
| Physician Executives | 1 | 2020 | 134 | 0.160 |
Why?
|
| Diagnosis, Differential | 9 | 2021 | 12974 | 0.160 |
Why?
|
| Ibuprofen | 1 | 2020 | 229 | 0.160 |
Why?
|
| Transcription Factor AP-2 | 1 | 2019 | 80 | 0.160 |
Why?
|
| Tracheostomy | 2 | 2000 | 426 | 0.160 |
Why?
|
| Diabetes Insipidus | 1 | 2019 | 144 | 0.160 |
Why?
|
| Fasciitis, Necrotizing | 1 | 1999 | 79 | 0.160 |
Why?
|
| Emergency Service, Hospital | 1 | 2018 | 7879 | 0.150 |
Why?
|
| Tonsillitis | 3 | 2020 | 28 | 0.150 |
Why?
|
| Pediatric Nursing | 1 | 1999 | 104 | 0.150 |
Why?
|
| Clarithromycin | 1 | 2018 | 86 | 0.150 |
Why?
|
| Nuclear Localization Signals | 1 | 1998 | 77 | 0.150 |
Why?
|
| Nuclear Pore Complex Proteins | 2 | 1996 | 163 | 0.150 |
Why?
|
| Perioperative Care | 1 | 2005 | 1033 | 0.150 |
Why?
|
| Arthrobacter | 1 | 2017 | 20 | 0.150 |
Why?
|
| Hematologic Diseases | 1 | 2021 | 496 | 0.140 |
Why?
|
| ABO Blood-Group System | 1 | 2020 | 380 | 0.140 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2020 | 370 | 0.140 |
Why?
|
| DNA-Binding Proteins | 3 | 2021 | 9606 | 0.140 |
Why?
|
| Mycobacteriophages | 1 | 2017 | 19 | 0.140 |
Why?
|
| Prophages | 1 | 2017 | 39 | 0.140 |
Why?
|
| Faculty | 1 | 2020 | 384 | 0.140 |
Why?
|
| Syndrome | 5 | 2016 | 3267 | 0.140 |
Why?
|
| Cleft Lip | 1 | 2022 | 506 | 0.140 |
Why?
|
| Hearing Loss, Central | 1 | 2016 | 14 | 0.140 |
Why?
|
| Retroelements | 1 | 1998 | 163 | 0.140 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2000 | 531 | 0.140 |
Why?
|
| Laryngoscopy | 5 | 2018 | 706 | 0.140 |
Why?
|
| Cleft Palate | 1 | 2022 | 589 | 0.140 |
Why?
|
| Postoperative Complications | 8 | 2010 | 15631 | 0.140 |
Why?
|
| Fungal Proteins | 3 | 2000 | 910 | 0.130 |
Why?
|
| Hereditary Autoinflammatory Diseases | 1 | 2016 | 42 | 0.130 |
Why?
|
| Pharynx | 1 | 1999 | 432 | 0.130 |
Why?
|
| Mycobacterium smegmatis | 1 | 2017 | 126 | 0.130 |
Why?
|
| Fingers | 1 | 2019 | 507 | 0.130 |
Why?
|
| DNA Replication | 1 | 2003 | 1418 | 0.130 |
Why?
|
| Phenotype | 10 | 2024 | 16591 | 0.130 |
Why?
|
| Reoperation | 3 | 2022 | 4303 | 0.130 |
Why?
|
| Personal Satisfaction | 1 | 2020 | 644 | 0.130 |
Why?
|
| Dizziness | 2 | 2015 | 259 | 0.130 |
Why?
|
| Hyperbilirubinemia | 1 | 2015 | 74 | 0.130 |
Why?
|
| Beckwith-Wiedemann Syndrome | 1 | 1995 | 45 | 0.130 |
Why?
|
| Tracheotomy | 4 | 1995 | 167 | 0.130 |
Why?
|
| Integrases | 1 | 1998 | 516 | 0.130 |
Why?
|
| Rubella | 1 | 2015 | 55 | 0.130 |
Why?
|
| Foreign Bodies | 3 | 2001 | 402 | 0.120 |
Why?
|
| Granular Cell Tumor | 1 | 1995 | 48 | 0.120 |
Why?
|
| Toxoplasmosis | 1 | 2015 | 94 | 0.120 |
Why?
|
| Tympanic Membrane | 3 | 2008 | 232 | 0.120 |
Why?
|
| Hoarseness | 1 | 1995 | 62 | 0.120 |
Why?
|
| Genetic Counseling | 2 | 2010 | 627 | 0.120 |
Why?
|
| Membrane Proteins | 5 | 2011 | 7856 | 0.120 |
Why?
|
| Head Injuries, Closed | 1 | 2015 | 133 | 0.120 |
Why?
|
| Receptors, Cell Surface | 1 | 2024 | 2822 | 0.120 |
Why?
|
| Physical Examination | 2 | 2018 | 1255 | 0.120 |
Why?
|
| Disease Progression | 4 | 2021 | 13506 | 0.120 |
Why?
|
| Neurologic Examination | 1 | 2017 | 916 | 0.110 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2000 | 612 | 0.110 |
Why?
|
| Patient Selection | 4 | 2012 | 4244 | 0.110 |
Why?
|
| Sequence Deletion | 2 | 2011 | 1494 | 0.110 |
Why?
|
| Centromere | 3 | 1989 | 212 | 0.110 |
Why?
|
| Databases as Topic | 1 | 2015 | 473 | 0.110 |
Why?
|
| Noise | 1 | 2015 | 290 | 0.110 |
Why?
|
| Magnetic Resonance Imaging | 8 | 2015 | 36426 | 0.110 |
Why?
|
| Chromosomes | 4 | 2006 | 577 | 0.110 |
Why?
|
| Syphilis | 1 | 2015 | 243 | 0.100 |
Why?
|
| Prosthesis Failure | 1 | 2018 | 1204 | 0.100 |
Why?
|
| Staphylococcal Infections | 1 | 2022 | 1408 | 0.100 |
Why?
|
| Periodicity | 3 | 2012 | 348 | 0.100 |
Why?
|
| Exoribonucleases | 1 | 1993 | 93 | 0.100 |
Why?
|
| Larynx | 1 | 2017 | 492 | 0.100 |
Why?
|
| Fistula | 2 | 1995 | 212 | 0.100 |
Why?
|
| Congenital Abnormalities | 1 | 2017 | 709 | 0.100 |
Why?
|
| Severity of Illness Index | 5 | 2021 | 15842 | 0.100 |
Why?
|
| Herpes Simplex | 1 | 2015 | 478 | 0.100 |
Why?
|
| Cell Cycle Proteins | 3 | 2021 | 3448 | 0.100 |
Why?
|
| Aminoglycosides | 3 | 2009 | 160 | 0.100 |
Why?
|
| Electrocoagulation | 2 | 2011 | 152 | 0.100 |
Why?
|
| Laryngeal Neoplasms | 1 | 1995 | 514 | 0.100 |
Why?
|
| Otologic Surgical Procedures | 3 | 2011 | 150 | 0.100 |
Why?
|
| Pseudomonas Infections | 4 | 1998 | 622 | 0.100 |
Why?
|
| Nose Neoplasms | 2 | 2003 | 249 | 0.100 |
Why?
|
| Genes, Fungal | 1 | 1993 | 439 | 0.090 |
Why?
|
| Reproducibility of Results | 5 | 2020 | 20098 | 0.090 |
Why?
|
| Perilymph | 2 | 1995 | 50 | 0.090 |
Why?
|
| Visual Acuity | 1 | 2021 | 2672 | 0.090 |
Why?
|
| Homozygote | 4 | 2011 | 1776 | 0.090 |
Why?
|
| Cautery | 1 | 2011 | 71 | 0.090 |
Why?
|
| Leadership | 1 | 2020 | 1385 | 0.090 |
Why?
|
| Gastroesophageal Reflux | 2 | 2003 | 819 | 0.090 |
Why?
|
| Petrous Bone | 1 | 2011 | 85 | 0.090 |
Why?
|
| Craniofacial Abnormalities | 2 | 2005 | 319 | 0.090 |
Why?
|
| Device Removal | 2 | 2022 | 630 | 0.090 |
Why?
|
| Genomics | 4 | 2020 | 5821 | 0.090 |
Why?
|
| Adult | 19 | 2021 | 221177 | 0.090 |
Why?
|
| Genetic Linkage | 1 | 2015 | 2341 | 0.090 |
Why?
|
| Labyrinthine Fluids | 1 | 1989 | 15 | 0.090 |
Why?
|
| Constriction, Pathologic | 2 | 2012 | 1096 | 0.090 |
Why?
|
| Retina | 1 | 2021 | 2659 | 0.090 |
Why?
|
| Counseling | 1 | 2018 | 1547 | 0.090 |
Why?
|
| Epiglottitis | 2 | 1986 | 19 | 0.080 |
Why?
|
| Pseudomonas aeruginosa | 5 | 1998 | 1277 | 0.080 |
Why?
|
| Laryngitis | 2 | 1986 | 27 | 0.080 |
Why?
|
| Practice Guidelines as Topic | 2 | 2014 | 7390 | 0.080 |
Why?
|
| Risk Assessment | 3 | 2015 | 23995 | 0.080 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2022 | 1875 | 0.080 |
Why?
|
| Case-Control Studies | 5 | 2020 | 22176 | 0.080 |
Why?
|
| Neoplasm Proteins | 1 | 2021 | 3617 | 0.080 |
Why?
|
| Forecasting | 1 | 2018 | 2928 | 0.080 |
Why?
|
| Saccule and Utricle | 1 | 2009 | 81 | 0.080 |
Why?
|
| Liver Transplantation | 1 | 2000 | 2330 | 0.080 |
Why?
|
| Granulation Tissue | 1 | 2008 | 92 | 0.080 |
Why?
|
| Respiration Disorders | 1 | 1992 | 367 | 0.080 |
Why?
|
| Tympanic Membrane Perforation | 1 | 2008 | 45 | 0.080 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 1988 | 166 | 0.080 |
Why?
|
| Cefaclor | 1 | 1987 | 8 | 0.080 |
Why?
|
| Health Surveys | 1 | 2018 | 4061 | 0.080 |
Why?
|
| Nutrition Surveys | 1 | 2015 | 1733 | 0.080 |
Why?
|
| Nucleoproteins | 1 | 1988 | 113 | 0.080 |
Why?
|
| DNA, Fungal | 2 | 1989 | 275 | 0.080 |
Why?
|
| Cefotaxime | 1 | 1987 | 35 | 0.070 |
Why?
|
| Cephalexin | 1 | 1987 | 37 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 2 | 2010 | 6075 | 0.070 |
Why?
|
| Digestive System | 1 | 1988 | 244 | 0.070 |
Why?
|
| Blood Coagulation Tests | 1 | 2008 | 271 | 0.070 |
Why?
|
| Stapedius | 1 | 2007 | 26 | 0.070 |
Why?
|
| Retinal Degeneration | 1 | 2011 | 413 | 0.070 |
Why?
|
| Respiratory Tract Diseases | 2 | 2003 | 750 | 0.070 |
Why?
|
| Analgesics | 1 | 2014 | 1070 | 0.070 |
Why?
|
| Cohort Studies | 8 | 2020 | 41487 | 0.070 |
Why?
|
| Fever | 2 | 2005 | 1618 | 0.070 |
Why?
|
| Incidence | 7 | 2021 | 21353 | 0.070 |
Why?
|
| Ear Ossicles | 1 | 2007 | 71 | 0.070 |
Why?
|
| Prospective Studies | 13 | 2016 | 54425 | 0.070 |
Why?
|
| RNA Splicing | 2 | 2022 | 918 | 0.070 |
Why?
|
| Mastoid | 1 | 2007 | 100 | 0.070 |
Why?
|
| Epidermolysis Bullosa | 1 | 1986 | 29 | 0.070 |
Why?
|
| Halitosis | 1 | 2005 | 13 | 0.070 |
Why?
|
| Telomere-Binding Proteins | 1 | 2007 | 119 | 0.070 |
Why?
|
| Vaccination | 1 | 2018 | 3384 | 0.060 |
Why?
|
| Base Composition | 2 | 2020 | 290 | 0.060 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2017 | 1914 | 0.060 |
Why?
|
| Water Pollutants | 1 | 1985 | 24 | 0.060 |
Why?
|
| Genetic Complementation Test | 3 | 1996 | 554 | 0.060 |
Why?
|
| United States | 6 | 2020 | 72334 | 0.060 |
Why?
|
| Fuel Oils | 1 | 1985 | 35 | 0.060 |
Why?
|
| Chromosome Aberrations | 2 | 2024 | 1768 | 0.060 |
Why?
|
| Quality of Life | 4 | 2021 | 13367 | 0.060 |
Why?
|
| Facial Nerve Diseases | 1 | 2005 | 49 | 0.060 |
Why?
|
| Language Development | 2 | 2020 | 183 | 0.060 |
Why?
|
| Petroleum | 1 | 1985 | 80 | 0.060 |
Why?
|
| Coal | 1 | 1985 | 122 | 0.060 |
Why?
|
| Intubation, Intratracheal | 4 | 2000 | 1329 | 0.060 |
Why?
|
| Preoperative Care | 2 | 2008 | 2242 | 0.060 |
Why?
|
| Respiratory System | 1 | 1988 | 563 | 0.060 |
Why?
|
| Checklist | 1 | 2012 | 827 | 0.060 |
Why?
|
| Drinking | 1 | 2005 | 198 | 0.060 |
Why?
|
| Visual Fields | 1 | 2011 | 1062 | 0.060 |
Why?
|
| Eustachian Tube | 2 | 2001 | 99 | 0.060 |
Why?
|
| Statistics as Topic | 1 | 2011 | 2358 | 0.060 |
Why?
|
| Encephalocele | 1 | 1985 | 135 | 0.060 |
Why?
|
| Facial Neoplasms | 1 | 2005 | 125 | 0.060 |
Why?
|
| Vision Disorders | 1 | 2011 | 1088 | 0.060 |
Why?
|
| Ear, External | 1 | 2005 | 165 | 0.060 |
Why?
|
| Chromosome Pairing | 1 | 2003 | 45 | 0.060 |
Why?
|
| Gene Expression Regulation, Fungal | 1 | 2006 | 495 | 0.060 |
Why?
|
| Prognosis | 6 | 2013 | 29625 | 0.060 |
Why?
|
| Papilloma | 1 | 1984 | 140 | 0.060 |
Why?
|
| Facial Injuries | 1 | 2005 | 190 | 0.060 |
Why?
|
| Replication Protein C | 1 | 2003 | 25 | 0.050 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 3416 | 0.050 |
Why?
|
| Cloning, Molecular | 4 | 2003 | 4174 | 0.050 |
Why?
|
| Logistic Models | 2 | 2015 | 13255 | 0.050 |
Why?
|
| Phylogeny | 3 | 2020 | 2811 | 0.050 |
Why?
|
| Staphylococcus aureus | 3 | 2022 | 1458 | 0.050 |
Why?
|
| Referral and Consultation | 3 | 2021 | 3600 | 0.050 |
Why?
|
| Radiography | 2 | 2011 | 6965 | 0.050 |
Why?
|
| Recurrence | 4 | 2005 | 8465 | 0.050 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2007 | 604 | 0.050 |
Why?
|
| Dermoid Cyst | 1 | 2003 | 92 | 0.050 |
Why?
|
| Iatrogenic Disease | 1 | 2005 | 539 | 0.050 |
Why?
|
| Multivariate Analysis | 1 | 2015 | 12059 | 0.050 |
Why?
|
| Fishes | 1 | 1985 | 603 | 0.050 |
Why?
|
| Age Distribution | 2 | 2005 | 2880 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2021 | 17904 | 0.050 |
Why?
|
| DNA, Viral | 2 | 2020 | 2202 | 0.050 |
Why?
|
| Simplexvirus | 1 | 2005 | 803 | 0.050 |
Why?
|
| Mediastinitis | 1 | 2001 | 49 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 3778 | 0.050 |
Why?
|
| RNA Splice Sites | 1 | 2022 | 211 | 0.050 |
Why?
|
| Mitomycin | 1 | 2002 | 263 | 0.050 |
Why?
|
| Esophagus | 2 | 2001 | 1033 | 0.050 |
Why?
|
| Esophageal Perforation | 1 | 2001 | 65 | 0.050 |
Why?
|
| Water Pollutants, Chemical | 1 | 1985 | 359 | 0.050 |
Why?
|
| Chronic Disease | 8 | 2006 | 9318 | 0.050 |
Why?
|
| Macaca fascicularis | 2 | 2020 | 903 | 0.050 |
Why?
|
| GPI-Linked Proteins | 1 | 2022 | 469 | 0.050 |
Why?
|
| Esophageal Stenosis | 1 | 2002 | 196 | 0.040 |
Why?
|
| Macromolecular Substances | 1 | 2003 | 1434 | 0.040 |
Why?
|
| Multicenter Studies as Topic | 1 | 2005 | 1702 | 0.040 |
Why?
|
| Telomere | 1 | 2007 | 943 | 0.040 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 1984 | 592 | 0.040 |
Why?
|
| Middle Aged | 11 | 2020 | 220895 | 0.040 |
Why?
|
| Silent Information Regulator Proteins, Saccharomyces cerevisiae | 1 | 2000 | 63 | 0.040 |
Why?
|
| Bone Conduction | 2 | 2011 | 102 | 0.040 |
Why?
|
| Malocclusion | 1 | 2001 | 131 | 0.040 |
Why?
|
| Treatment Outcome | 11 | 2021 | 64680 | 0.040 |
Why?
|
| Viral Fusion Proteins | 1 | 2020 | 100 | 0.040 |
Why?
|
| Facial Asymmetry | 1 | 2001 | 172 | 0.040 |
Why?
|
| Chromatin | 3 | 2006 | 2960 | 0.040 |
Why?
|
| Internship and Residency | 1 | 2020 | 5880 | 0.040 |
Why?
|
| Cricoid Cartilage | 1 | 2000 | 69 | 0.040 |
Why?
|
| Acupressure | 1 | 1999 | 16 | 0.040 |
Why?
|
| Aged | 7 | 2020 | 169289 | 0.040 |
Why?
|
| Protein Subunits | 1 | 2003 | 943 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2024 | 1699 | 0.040 |
Why?
|
| Nursing Assessment | 1 | 1999 | 106 | 0.040 |
Why?
|
| Recurrent Laryngeal Nerve | 1 | 2000 | 143 | 0.040 |
Why?
|
| Base Sequence | 4 | 2009 | 12441 | 0.040 |
Why?
|
| Genes, Viral | 1 | 2020 | 649 | 0.040 |
Why?
|
| Jews | 1 | 2021 | 356 | 0.040 |
Why?
|
| Eating | 1 | 2005 | 1539 | 0.040 |
Why?
|
| Molecular Sequence Data | 5 | 2003 | 17635 | 0.040 |
Why?
|
| Otoscopes | 1 | 1998 | 13 | 0.040 |
Why?
|
| Histone Demethylases | 1 | 2021 | 320 | 0.040 |
Why?
|
| Developmental Disabilities | 1 | 2007 | 1509 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2019 | 277 | 0.040 |
Why?
|
| Risk Factors | 5 | 2020 | 74206 | 0.040 |
Why?
|
| Cell Nucleus | 3 | 2003 | 2909 | 0.040 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2022 | 829 | 0.040 |
Why?
|
| Decision Making | 1 | 2012 | 3929 | 0.040 |
Why?
|
| Amino Acid Sequence | 3 | 2003 | 13446 | 0.040 |
Why?
|
| Conserved Sequence | 2 | 2003 | 1163 | 0.040 |
Why?
|
| Cerebrospinal Fluid Otorrhea | 2 | 1996 | 15 | 0.040 |
Why?
|
| Thoracic Surgery, Video-Assisted | 1 | 2000 | 285 | 0.040 |
Why?
|
| Heterozygote | 3 | 2011 | 2787 | 0.040 |
Why?
|
| Primates | 1 | 2020 | 523 | 0.040 |
Why?
|
| Lysogeny | 1 | 2017 | 67 | 0.040 |
Why?
|
| Infant, Premature | 1 | 1987 | 2107 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2003 | 2748 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2019 | 638 | 0.030 |
Why?
|
| Histones | 3 | 2003 | 2580 | 0.030 |
Why?
|
| Ciprofloxacin | 1 | 1998 | 312 | 0.030 |
Why?
|
| Delayed Diagnosis | 1 | 2020 | 463 | 0.030 |
Why?
|
| Transgenes | 1 | 2020 | 1010 | 0.030 |
Why?
|
| Exons | 1 | 2022 | 2391 | 0.030 |
Why?
|
| Familial Mediterranean Fever | 1 | 2016 | 65 | 0.030 |
Why?
|
| Injections, Intravenous | 2 | 2001 | 1379 | 0.030 |
Why?
|
| Electrodes, Implanted | 1 | 2021 | 840 | 0.030 |
Why?
|
| Turkey | 1 | 2016 | 254 | 0.030 |
Why?
|
| NAD | 1 | 2000 | 614 | 0.030 |
Why?
|
| Nausea | 1 | 1999 | 679 | 0.030 |
Why?
|
| DNA Helicases | 1 | 2021 | 851 | 0.030 |
Why?
|
| Germ-Line Mutation | 1 | 2024 | 1858 | 0.030 |
Why?
|
| Otitis Externa | 1 | 1995 | 17 | 0.030 |
Why?
|
| Otoacoustic Emissions, Spontaneous | 1 | 2016 | 139 | 0.030 |
Why?
|
| Cicatrix | 1 | 2002 | 798 | 0.030 |
Why?
|
| Vomiting | 1 | 1999 | 651 | 0.030 |
Why?
|
| Papain | 1 | 1975 | 65 | 0.030 |
Why?
|
| Histone Deacetylases | 1 | 2000 | 719 | 0.030 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2005 | 1809 | 0.030 |
Why?
|
| Ear Cartilage | 1 | 1995 | 62 | 0.030 |
Why?
|
| Hospitalization | 1 | 2015 | 10723 | 0.030 |
Why?
|
| Ligases | 1 | 2017 | 333 | 0.030 |
Why?
|
| Tracheal Stenosis | 2 | 2002 | 228 | 0.030 |
Why?
|
| Palatine Tonsil | 1 | 1995 | 193 | 0.030 |
Why?
|
| Bacteria | 1 | 1986 | 2199 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2005 | 2979 | 0.030 |
Why?
|
| Dependovirus | 1 | 2020 | 718 | 0.030 |
Why?
|
| Patient Care Team | 2 | 2012 | 2521 | 0.030 |
Why?
|
| Likelihood Functions | 2 | 2009 | 992 | 0.030 |
Why?
|
| Acupuncture Therapy | 1 | 1999 | 486 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1998 | 1693 | 0.030 |
Why?
|
| Porins | 1 | 1994 | 78 | 0.030 |
Why?
|
| S Phase | 2 | 2006 | 421 | 0.030 |
Why?
|
| Codeine | 1 | 2014 | 51 | 0.030 |
Why?
|
| Animals | 10 | 2024 | 168459 | 0.030 |
Why?
|
| Quinolinic Acid | 1 | 1994 | 67 | 0.030 |
Why?
|
| Transferrin | 1 | 1995 | 283 | 0.030 |
Why?
|
| Apnea | 1 | 1995 | 195 | 0.030 |
Why?
|
| Blood Transfusion | 1 | 2020 | 1298 | 0.030 |
Why?
|
| Follow-Up Studies | 6 | 2018 | 39106 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2024 | 5439 | 0.030 |
Why?
|
| Trachea | 1 | 2000 | 1089 | 0.030 |
Why?
|
| Hospitals, Pediatric | 1 | 2003 | 1860 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2018 | 1813 | 0.030 |
Why?
|
| Intraoperative Care | 1 | 1997 | 767 | 0.030 |
Why?
|
| Apolipoproteins E | 1 | 1998 | 1444 | 0.030 |
Why?
|
| DNA Copy Number Variations | 1 | 2021 | 2020 | 0.030 |
Why?
|
| Immunologic Techniques | 1 | 1993 | 212 | 0.030 |
Why?
|
| Tongue | 1 | 1995 | 403 | 0.030 |
Why?
|
| Mutagenesis | 1 | 1996 | 1232 | 0.020 |
Why?
|
| Databases, Genetic | 1 | 2019 | 1742 | 0.020 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2007 | 3708 | 0.020 |
Why?
|
| Electrophoresis, Agar Gel | 2 | 1989 | 207 | 0.020 |
Why?
|
| DNA Primers | 1 | 1996 | 2819 | 0.020 |
Why?
|
| DNA Restriction Enzymes | 2 | 1989 | 550 | 0.020 |
Why?
|
| Genome, Bacterial | 1 | 2017 | 783 | 0.020 |
Why?
|
| Time Factors | 5 | 2005 | 39967 | 0.020 |
Why?
|
| Sensitivity and Specificity | 4 | 2015 | 14666 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 2 | 2018 | 4740 | 0.020 |
Why?
|
| Hypertrophy | 1 | 2013 | 561 | 0.020 |
Why?
|
| Sequence Analysis | 1 | 2011 | 240 | 0.020 |
Why?
|
| Anti-Infective Agents | 1 | 1998 | 983 | 0.020 |
Why?
|
| Medical History Taking | 1 | 1995 | 774 | 0.020 |
Why?
|
| Visual Cortex | 1 | 1998 | 1107 | 0.020 |
Why?
|
| Administration, Topical | 3 | 2002 | 704 | 0.020 |
Why?
|
| Dark Adaptation | 1 | 2011 | 222 | 0.020 |
Why?
|
| Trans-Activators | 1 | 2000 | 2856 | 0.020 |
Why?
|
| Postoperative Care | 1 | 1997 | 1468 | 0.020 |
Why?
|
| Vocal Cords | 1 | 1995 | 522 | 0.020 |
Why?
|
| Deglutition | 1 | 1992 | 208 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2020 | 3395 | 0.020 |
Why?
|
| Mutagenesis, Insertional | 1 | 1993 | 656 | 0.020 |
Why?
|
| Electromyography | 2 | 2009 | 1394 | 0.020 |
Why?
|
| Photoreceptor Cells, Vertebrate | 1 | 2011 | 203 | 0.020 |
Why?
|
| Zebrafish | 1 | 2021 | 3007 | 0.020 |
Why?
|
| Viral Proteins | 1 | 2017 | 1804 | 0.020 |
Why?
|
| Erythrocytes | 2 | 1976 | 2413 | 0.020 |
Why?
|
| Monocytes | 2 | 1976 | 2570 | 0.020 |
Why?
|
| Biopsy, Needle | 2 | 2011 | 1626 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2021 | 3639 | 0.020 |
Why?
|
| Endoscopy | 1 | 1999 | 1851 | 0.020 |
Why?
|
| HIV Infections | 1 | 2015 | 17351 | 0.020 |
Why?
|
| Deoxyribonuclease BamHI | 1 | 1988 | 17 | 0.020 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 1984 | 4026 | 0.020 |
Why?
|
| Temperature | 2 | 2006 | 2226 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2024 | 14414 | 0.020 |
Why?
|
| Ion Transport | 1 | 2009 | 319 | 0.020 |
Why?
|
| Cefixime | 1 | 1987 | 13 | 0.020 |
Why?
|
| Cysts | 1 | 1993 | 681 | 0.020 |
Why?
|
| ROC Curve | 1 | 2015 | 3579 | 0.020 |
Why?
|
| Evoked Potentials, Auditory, Brain Stem | 1 | 2009 | 253 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1996 | 3734 | 0.020 |
Why?
|
| Tympanoplasty | 1 | 1987 | 73 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2011 | 1217 | 0.020 |
Why?
|
| Neurons | 2 | 1998 | 9463 | 0.020 |
Why?
|
| Visual Perception | 1 | 2015 | 1387 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1988 | 1302 | 0.020 |
Why?
|
| Models, Biological | 1 | 2003 | 9469 | 0.020 |
Why?
|
| Pain | 1 | 2022 | 5073 | 0.020 |
Why?
|
| Cadaver | 1 | 2011 | 1358 | 0.020 |
Why?
|
| Phosphoproteins | 2 | 2006 | 2448 | 0.020 |
Why?
|
| Infant, Premature, Diseases | 1 | 1992 | 710 | 0.020 |
Why?
|
| Chlorides | 1 | 2009 | 665 | 0.020 |
Why?
|
| Algorithms | 3 | 2017 | 14031 | 0.020 |
Why?
|
| Infant, Low Birth Weight | 2 | 1992 | 870 | 0.020 |
Why?
|
| Societies, Medical | 1 | 2018 | 3905 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2019 | 15936 | 0.020 |
Why?
|
| Parents | 1 | 2020 | 3563 | 0.020 |
Why?
|
| Age Factors | 2 | 2015 | 18395 | 0.020 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 1 | 2006 | 141 | 0.020 |
Why?
|
| Corynebacterium | 1 | 1986 | 48 | 0.020 |
Why?
|
| Specimen Handling | 1 | 2011 | 702 | 0.020 |
Why?
|
| Neuroma, Acoustic | 1 | 2010 | 459 | 0.020 |
Why?
|
| Haemophilus Infections | 1 | 1986 | 94 | 0.020 |
Why?
|
| Mice | 3 | 2024 | 81525 | 0.020 |
Why?
|
| Haemophilus influenzae | 1 | 1986 | 178 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2009 | 1541 | 0.020 |
Why?
|
| Evoked Potentials, Auditory | 1 | 2009 | 530 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 1993 | 2113 | 0.020 |
Why?
|
| Xenopus laevis | 1 | 2009 | 963 | 0.020 |
Why?
|
| Disease Models, Animal | 2 | 2021 | 18252 | 0.010 |
Why?
|
| Drug Evaluation | 1 | 1986 | 641 | 0.010 |
Why?
|
| Lung Volume Measurements | 1 | 1985 | 375 | 0.010 |
Why?
|
| Sphenoid Bone | 1 | 1985 | 177 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2020 | 7967 | 0.010 |
Why?
|
| Bronchoscopy | 3 | 2000 | 909 | 0.010 |
Why?
|
| Immunoglobulin G | 2 | 1976 | 4544 | 0.010 |
Why?
|
| Otoscopy | 1 | 2004 | 40 | 0.010 |
Why?
|
| Oocytes | 1 | 2009 | 1166 | 0.010 |
Why?
|
| Mastoiditis | 1 | 1984 | 37 | 0.010 |
Why?
|
| Ear Diseases | 1 | 1986 | 180 | 0.010 |
Why?
|
| Microbial Sensitivity Tests | 2 | 1995 | 1937 | 0.010 |
Why?
|
| Evoked Potentials | 1 | 2010 | 1038 | 0.010 |
Why?
|
| Boston | 1 | 2016 | 9326 | 0.010 |
Why?
|
| Reference Values | 1 | 2011 | 4920 | 0.010 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2004 | 460 | 0.010 |
Why?
|
| Genome, Fungal | 1 | 2004 | 203 | 0.010 |
Why?
|
| Pulmonary Ventilation | 1 | 1985 | 372 | 0.010 |
Why?
|
| Protein Binding | 2 | 2007 | 9351 | 0.010 |
Why?
|
| Tidal Volume | 1 | 1985 | 488 | 0.010 |
Why?
|
| G1 Phase | 1 | 2004 | 403 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2009 | 1971 | 0.010 |
Why?
|
| China | 1 | 2009 | 2369 | 0.010 |
Why?
|
| Speech Disorders | 1 | 2004 | 180 | 0.010 |
Why?
|
| Language Development Disorders | 1 | 2004 | 193 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 2004 | 565 | 0.010 |
Why?
|
| Immunohistochemistry | 2 | 2011 | 11076 | 0.010 |
Why?
|
| Paranasal Sinus Neoplasms | 1 | 1984 | 242 | 0.010 |
Why?
|
| Choanal Atresia | 1 | 2002 | 41 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2012 | 6343 | 0.010 |
Why?
|
| Cross-Sectional Studies | 3 | 2013 | 26125 | 0.010 |
Why?
|
| Immunoprecipitation | 1 | 2004 | 878 | 0.010 |
Why?
|
| Canada | 1 | 2007 | 2122 | 0.010 |
Why?
|
| Pediatrics | 1 | 2016 | 3589 | 0.010 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2006 | 727 | 0.010 |
Why?
|
| Gene Amplification | 1 | 1985 | 1089 | 0.010 |
Why?
|
| Sudden Infant Death | 1 | 2003 | 292 | 0.010 |
Why?
|
| Pain Measurement | 1 | 2011 | 3550 | 0.010 |
Why?
|
| Tongue Neoplasms | 1 | 1982 | 183 | 0.010 |
Why?
|
| Diagnostic Imaging | 1 | 1995 | 3530 | 0.010 |
Why?
|
| Mass Screening | 1 | 2016 | 5428 | 0.010 |
Why?
|
| Nasal Polyps | 1 | 1985 | 395 | 0.010 |
Why?
|
| Intubation, Gastrointestinal | 1 | 2001 | 166 | 0.010 |
Why?
|
| Laryngostenosis | 1 | 2002 | 167 | 0.010 |
Why?
|
| Sirtuin 2 | 1 | 2000 | 95 | 0.010 |
Why?
|
| Calcium-Binding Proteins | 1 | 2004 | 1069 | 0.010 |
Why?
|
| Oncogenes | 1 | 1985 | 1222 | 0.010 |
Why?
|
| Psychotherapy | 1 | 1969 | 1647 | 0.010 |
Why?
|
| Respiratory Sounds | 1 | 2003 | 702 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2003 | 2180 | 0.010 |
Why?
|
| Mitosis | 1 | 2004 | 1187 | 0.010 |
Why?
|
| Shock, Septic | 1 | 1986 | 768 | 0.010 |
Why?
|
| Esophagoscopy | 1 | 2001 | 396 | 0.010 |
Why?
|
| DNA, Ribosomal | 1 | 2000 | 300 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 15266 | 0.010 |
Why?
|
| Polymyxin B | 1 | 1998 | 44 | 0.010 |
Why?
|
| Quantitative Trait Loci | 1 | 2007 | 2116 | 0.010 |
Why?
|
| Drug Therapy, Combination | 2 | 1986 | 6310 | 0.010 |
Why?
|
| Sirtuin 1 | 1 | 2000 | 246 | 0.010 |
Why?
|
| Neomycin | 1 | 1998 | 92 | 0.010 |
Why?
|
| Foreign-Body Migration | 1 | 2000 | 219 | 0.010 |
Why?
|
| Cytoskeletal Proteins | 1 | 2004 | 1342 | 0.010 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2003 | 611 | 0.010 |
Why?
|
| Drainage | 1 | 1984 | 1157 | 0.010 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2000 | 426 | 0.010 |
Why?
|
| Tomography, Optical Coherence | 1 | 2011 | 2917 | 0.010 |
Why?
|
| Gestational Age | 1 | 1987 | 3577 | 0.010 |
Why?
|
| Bacterial Infections | 1 | 1986 | 1390 | 0.010 |
Why?
|
| Communication | 1 | 2012 | 3873 | 0.010 |
Why?
|
| HeLa Cells | 1 | 2003 | 3093 | 0.010 |
Why?
|
| Sirtuins | 1 | 2000 | 320 | 0.010 |
Why?
|
| Causality | 1 | 2003 | 1242 | 0.010 |
Why?
|
| Alzheimer Disease | 1 | 1998 | 8599 | 0.010 |
Why?
|
| Patient Compliance | 1 | 1987 | 2690 | 0.010 |
Why?
|
| Respiratory Insufficiency | 1 | 1986 | 1230 | 0.010 |
Why?
|
| Concanavalin A | 1 | 1976 | 190 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2011 | 12341 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2003 | 3792 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2010 | 7827 | 0.010 |
Why?
|
| Sinusitis | 1 | 1985 | 991 | 0.010 |
Why?
|
| Immune Adherence Reaction | 1 | 1975 | 29 | 0.010 |
Why?
|
| Hemagglutination Tests | 1 | 1975 | 76 | 0.010 |
Why?
|
| Cochlear Aqueduct | 1 | 1995 | 7 | 0.010 |
Why?
|
| Oval Window, Ear | 1 | 1995 | 21 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2000 | 2281 | 0.010 |
Why?
|
| Linear Models | 1 | 2005 | 5871 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 2000 | 1519 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2013 | 11903 | 0.010 |
Why?
|
| Antigen-Antibody Reactions | 1 | 1975 | 340 | 0.010 |
Why?
|
| Rh-Hr Blood-Group System | 1 | 1975 | 63 | 0.010 |
Why?
|
| Binding Sites, Antibody | 1 | 1975 | 337 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2003 | 4615 | 0.010 |
Why?
|
| Immune Sera | 1 | 1975 | 606 | 0.010 |
Why?
|
| Evolution, Molecular | 1 | 2003 | 1886 | 0.010 |
Why?
|
| Terminology as Topic | 1 | 2002 | 1530 | 0.010 |
Why?
|
| alpha Karyopherins | 1 | 1994 | 40 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 1985 | 10766 | 0.010 |
Why?
|
| Audiometry, Evoked Response | 1 | 1994 | 45 | 0.010 |
Why?
|
| Round Window, Ear | 1 | 1994 | 47 | 0.010 |
Why?
|
| Genes, Lethal | 1 | 1994 | 223 | 0.010 |
Why?
|
| Chinchilla | 1 | 1994 | 75 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 1994 | 814 | 0.010 |
Why?
|
| Colonic Neoplasms | 1 | 1985 | 2538 | 0.010 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 1994 | 353 | 0.010 |
Why?
|
| Mouth Breathing | 1 | 1992 | 25 | 0.010 |
Why?
|
| Prevalence | 1 | 1989 | 15732 | 0.010 |
Why?
|
| Drug Combinations | 1 | 1998 | 2048 | 0.010 |
Why?
|
| Maxillofacial Development | 1 | 1992 | 87 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2011 | 12690 | 0.010 |
Why?
|
| Complement System Proteins | 1 | 1975 | 736 | 0.010 |
Why?
|
| RNA, Messenger | 2 | 2003 | 12795 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 1984 | 8529 | 0.010 |
Why?
|
| Sepsis | 1 | 1986 | 2585 | 0.010 |
Why?
|
| Immunization | 1 | 1975 | 1228 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2007 | 14605 | 0.010 |
Why?
|
| Wound Healing | 1 | 2002 | 2805 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2011 | 58976 | 0.010 |
Why?
|
| Hydrocortisone | 1 | 1998 | 1819 | 0.010 |
Why?
|
| Immunoglobulin M | 1 | 1975 | 1527 | 0.010 |
Why?
|
| Stents | 1 | 2002 | 3179 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 1976 | 3087 | 0.010 |
Why?
|
| DNA | 1 | 2003 | 7212 | 0.010 |
Why?
|
| Pulmonary Edema | 1 | 1992 | 409 | 0.010 |
Why?
|
| Enuresis | 1 | 1969 | 50 | 0.010 |
Why?
|
| Rabbits | 1 | 1975 | 4772 | 0.010 |
Why?
|
| Comorbidity | 1 | 2003 | 10508 | 0.000 |
Why?
|
| Mental Disorders | 1 | 1969 | 6845 | 0.000 |
Why?
|
| DNA Topoisomerases, Type II | 1 | 1989 | 122 | 0.000 |
Why?
|
| Blotting, Western | 1 | 1995 | 5035 | 0.000 |
Why?
|
| Dimethylhydrazines | 1 | 1985 | 12 | 0.000 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 1984 | 9280 | 0.000 |
Why?
|
| Delivery of Health Care | 1 | 2004 | 5336 | 0.000 |
Why?
|
| Arnold-Chiari Malformation | 1 | 1987 | 158 | 0.000 |
Why?
|
| Poly A | 1 | 1985 | 181 | 0.000 |
Why?
|
| Nucleosomes | 1 | 1989 | 487 | 0.000 |
Why?
|
| Amoxicillin | 1 | 1985 | 180 | 0.000 |
Why?
|
| RNA, Neoplasm | 1 | 1985 | 750 | 0.000 |
Why?
|
| Injections | 1 | 1985 | 830 | 0.000 |
Why?
|
| Cell Cycle | 1 | 1989 | 2932 | 0.000 |
Why?
|
| DNA, Neoplasm | 1 | 1985 | 1745 | 0.000 |
Why?
|
| Administration, Oral | 1 | 1985 | 4021 | 0.000 |
Why?
|
| Drug Administration Schedule | 1 | 1985 | 4853 | 0.000 |
Why?
|
| Receptors, Concanavalin A | 1 | 1976 | 11 | 0.000 |
Why?
|
| Mice, Inbred BALB C | 1 | 1985 | 6216 | 0.000 |
Why?
|
| Osmolar Concentration | 1 | 1976 | 659 | 0.000 |
Why?
|
| Lymphatic Metastasis | 1 | 1982 | 2915 | 0.000 |
Why?
|
| Anxiety | 1 | 1969 | 4573 | 0.000 |
Why?
|
| Risk | 1 | 1985 | 9610 | 0.000 |
Why?
|
| Lymph Nodes | 1 | 1982 | 3466 | 0.000 |
Why?
|
| Phagocytosis | 1 | 1976 | 1528 | 0.000 |
Why?
|
| Depression | 1 | 1969 | 8124 | 0.000 |
Why?
|
| Kinetics | 1 | 1976 | 6374 | 0.000 |
Why?
|
| Aging | 1 | 1987 | 8708 | 0.000 |
Why?
|
| Binding Sites | 1 | 1976 | 6055 | 0.000 |
Why?
|